DIRECT BIOLOGICS
LIVE

Serial Number

99361536

Owner

Direct Biologics, LLC

Attorney

Aaron D. Hendelman

Filing Date

Aug 27, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DIRECT BIOLOGICS Trademark

Serial Number: 99361536

DIRECT BIOLOGICS is a trademark filed by Direct Biologics, LLC on August 27, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Direct Biologics, LLC

5301 Southwest Parkway, Bldg 1, Ste 415
Austin, TX 78735

Entity Type: 16

Trademark Details

Filing Date

August 27, 2025

Registration Date

Not Registered

Published for Opposition

June 2, 2026

Goods & Services

Exosomes for use in the manufacture of cosmetics and pharmaceuticals

Gene therapy; cell therapy; services in the field of regenerative medicine; diagnosing the need for, and administering, regenerative medicine; regenerative medicine services

Pharmaceutical and therapeutic preparations for the treatment of inflammation, inflammation-derived diseases, acute respiratory disease syndrome (ARDS), Crohn’s disease, perianal fistulizing disease, colitis, pulmonary fibrosis, hair loss, alopecia, psoriasis, ulcers, joint pain, discogenic pain, lumbar and cervical radiculopathy, osteoarthritis, COVID-19, hip labral tears, traumatic brain injury, amyotrophic lateral sclerosis (ALS), chronic regional pain syndrome (CRPS), facial nerve damage, Bell’s Palsey, Ehler’s Danlos Disease, wound care, and skin damage; pharmaceutical and therapeutic preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders; regenerative medicine, namely, pharmaceuticals and therapeutics for the treatment of inflammation, inflammation-derived diseases, acute respiratory disease syndrome (ARDS), Crohn’s disease, perianal fistulizing disease, colitis, pulmonary fibrosis, hair loss, alopecia, psoriasis, ulcers, joint pain, discogenic pain, lumbar and cervical radiculopathy, osteoarthritis, COVID-19, hip labral tears, traumatic brain injury, amyotrophic lateral sclerosis (ALS), chronic regional pain syndrome (CRPS), facial nerve damage, Bell’s Palsey, Ehler’s Danlos Disease, wound care, and skin damage; regenerative medicine, namely, pharmaceuticals and therapeutics for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 2, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 2, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 21, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 19, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 27, 2025 MAFR
NEW APPLICATION ENTERED
Aug 27, 2025 NWAP